RNU7-176P

Across TCGA pan-cancer cohorts, RNU7-176P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU7-176P data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RNU7-176P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-176P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

CESC, UCS, and LIHC are the cancer types where RNU7-176P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	II,III,IV	0.124	0.759	<.001	72	view →
UCS	OS	Tertile	All	0.135	0.687	.009	72	view →
LIHC	DFS	Tertile	All	0.111	0.545	.001	54	view →
KIRC	OS	Tertile	All	0.435	0.673	.014	42	view →
STAD	OS	Tertile	IV	1.000	0.309	.034	36	view →
CHOL	DFS	Tertile	All	0.037	0.486	.001	18	view →
LUAD	OS	Tertile	All	0.355	0.791	<.001	18	view →
BRCA	DFS	Tertile	All	0.204	0.529	.021	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU7-176P–CESC (OS)

Open the CESC breakdown →